A carregar...

Allogeneic stem cell transplantation with alemtuzumab-based conditioning for patients with advanced chronic myelogenous leukemia

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the treatment of choice for patients with chronic myelogenous leukemia (CML) who have failed or are intolerant to tyrosine kinase inhibitors (TKI). Myeloablative conditioning regimens have been associated with high treatment-related m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: POIRÉ, XAVIER, ARTZ, ANDREW, LARSON, RICHARD A., KLINE, JUSTIN, ODENIKE, OLATOYOSI, RICH, ELIZABETH, GODLEY, LUCY, STOCK, WENDY, BESIEN, KOEN VAN
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3617055/
https://ncbi.nlm.nih.gov/pubmed/19142796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428190802626624
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!